MedTrace Logo

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT01137643 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2025-10-27

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Conditions

  • Chronic Myeloproliferative Disorders
  • Leukemia
  • Lymphoma
  • Lymphoproliferative Disorder
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Neoplasms
  • Nonmalignant Neoplasm

Interventions

OTHER

biologic sample preservation procedure

All samples collected during routine clinical care.

OTHER

cytology specimen collection procedure

All Samples collected during routine clinical care.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Paul Armistead, MD · UNC Lineberger Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2040-07-31
Completion
2040-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01137643 on ClinicalTrials.gov